Der foreligger omfattende post- marketing sikkerhedsdata baseret på humant luteniseringshormon (hLH) indeholdende urinderiverede lægemidler.
There is considerable post-marketing safety experience with human luteinising hormone (hLH)- containing medicinal products of urinary origin.